Articles tagged "Kidney"

2021 American Transplant Congress
Obesity is a Risk Factor for Progression to Kidney Transplant Waitlisting After Liver Transplantation
B. Shelton¹, B. Orandi¹, K. Olthoff², E. Pomfret³, K. Forde², D. Sawinski², M. Gray¹, N. Ascher⁴, J. Locke¹
¹University of Alabama at Birmingham, Birmingham, AL, ²University of Pennsylvania, Philadelphia, PA, ³University of Colorado School of Medicine, Aurora, CO, ⁴University of California San Francisco, San Francisco, CA
*Purpose: Non-alcoholic steatohepatitis (NASH) has emerged as a leading cause of cirrhosis, and obesity-associated comorbid conditions, including renal disease have become more prevalent. Obesity predisposes…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Kidney Transplant Recipients in Pre-vaccine Era
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: To study clinical characteristics and short-term outcomes in kidney transplant recipients who were previously infected with SARS-CoV-2*Methods: In this retrospective, single-center case-series, we identified…
2021 American Transplant Congress
Impact of Donor Kidney Biopsy on Kidney Yield and Post-Transplant Outcomes
C. Wang¹, J. Wetmore¹, A. Wey², N. Salkowski², J. Snyder², A. Israni¹
¹Nephrology, Hennepin County Medical Center, Minneapolis, MN, ²Scientific Registry of Transplant Recipients, Minneapolis, MN
*Purpose: Kidney procurement biopsy findings, such as Glomerulosclerosis (GS) is frequently used to determine kidney quality, but it remains unclear the degree of GS in…
2021 American Transplant Congress
Long Term Outcomes of Kidney Donors with Fibromuscular Dysplasia
H. N. Adrogue¹, A. Evans¹, S. A. Hebert¹, H. E. Adrogue¹, D. T. Nguyen², D. Murad¹, E. A. Graviss²
¹Medicine, Houston Methodist Hospital, Houston, TX, ²Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX
*Purpose: Fibromuscular dysplasia (FMD) is not an infrequent finding during kidney donor evaluation. Current guidelines do not provide any recommendations regarding the use of kidneys…
2021 American Transplant Congress
Urinary Exosome Mrna Signature for the Diagnosis of Human Kidney Transplant Rejection
R. El Fekih¹, J. Hurley², V. Tadigotla², A. Alghamdi³, A. Srivastava⁴, C. Coticchia², J. Choi¹, H. Allos⁵, k. yatim⁵, J. Alhaddad⁵, S. Eskandari⁵, P. Chu⁵, A. Mihali⁵, I. Lape⁵, M. Lima Filho⁵, B. Ayoma⁵, A. Chandraker⁵, K. Safa⁶, J. Markmann⁶, L. Riella⁶, R. Formica⁷, J. Skog², J. Azzi⁵
¹Medecine, Brigham and Women Hospital, Boston, MA, ²Exosome Diagnostics, Boston, MA, ³Boston Children Hospital, Boston, MA, ⁴Center for Translational Metabolism and Health, Chicago, IL, ⁵Transplantation Research Center, Boston, MA, ⁶Massachusetts General Hospital, Boston, MA, ⁷Yale School of Medicine, New Haven, CT
*Purpose: Traditional biomarkers currently used to monitor the kidney allograft, such as creatinine and proteinuria, are late markers of injury and lack sensitivity, specificity and…
2021 American Transplant Congress
Real-world Treatment Patterns of Antiviral Agents for Cytomegalovirus Among Adult Kidney Transplant Recipients: A USRDS-Medicare Linked Database Study
A. D. Raval¹, M. Ganz², P. Saravanan², Y. Tang¹, C. A. Santos³
¹Merck & Co., Inc., Kenilworth, NJ, ²Evidera, Inc., Waltham, MA, ³Rush University Medical Center, Chicago, IL
*Purpose: Cytomegalovirus (CMV) is a common viral pathogen among kidney transplant recipients (KTRs). Although guidelines recommend the use of prophylaxis or pre-emptive antiviral (AV) therapy…
2021 American Transplant Congress
Association of Delayed Graft Function with Mortality Post-kidney Transplantation
N. Eguchi¹, H. Ichii², F. J. Ferrey¹, U. G. Reddy¹, D. C. Dafoe², H. Seo³, K. Kalantar-Zadeh¹, E. Tantisattamo¹
¹Division of Nephrology, Hypertension and Kidney Transplantation, Department of Medicine, University of California Irvine, Orange, CA, ²Division of Kidney and Pancreas Transplantation, Department of Surgery, University of California Irvine, Orange, CA, ³School of Pharmacy and Pharmaceutical Sciences, University of California Irvine, Irvine, CA
*Purpose: Given the ongoing shortage of donated organs, marginal kidneys with a higher possibility of delayed graft function(DGF) have been increasingly utilized. While DGF in…
2021 American Transplant Congress
Robotic Assisted Donor Nephrectomy: A Single Center Experience
A. Khan, A. Sharma, S. Lee, A. Cotterell, D. Kumar, L. Kamal, I. Moinuddin, D. Bruno, V. Kumaran, M. Levy, C. Bhati
Transplant Surgery, Virginia Commonwealth University, Richmond, VA
*Purpose: Robotic donor nephrectomy (RLDN) is an emerging procedure of choice for living kidney donors at many programs. This approach has benefit of minimal invasive…
2021 American Transplant Congress
Long-Term Renal Outcomes in Lung Transplant Recipients- A Single-Center Five-Year Experience
M. Doraiswamy, E. Obole, P. Singh, T. Pesavento
Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH
*Purpose: The increased longevity in Lung transplant (LTx) has led to an upsurge in chronic medical comorbidities, including Acute kidney injury (AKI), Chronic kidney disease…
2021 American Transplant Congress
Short Term Outcomes in Previously Covid Positive Living Kidney Donors and Their Recipients
R. Prashar, N. J. Khoury, M. Ramesh, A. K. Patel
Henry Ford Transplant Institute, Detroit, MI
*Purpose: Study short term outcomes of living kidney donors (LKD) who were previously infected with COVID 19, and in their recipients.*Methods: After a brief hiatus…